United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$19Mraised across 4 rounds since 2013, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
National Science Foundation
Alumni Ventures
Norwest Venture Partners
Sands Capital Ventures
Blackhorn VenturesSource recorded
Reported by FinSMEsSEC filing: $7.4M sold, first sale Oct 2019
From CytoVale's own website and the SEC filings it signed: 7 on the team.
On the board, as filediJordanna Polis SchutzLindy Fishburne
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Blackhorn VenturesNational Science FoundationAlumni VenturesNorwest Venture PartnersSands Capital Ventures
Dolby Family Ventures
Breakout Labs
Breakout VenturesMissing a round, or an investor who was in one? Tell us.
These 3 firms list CytoVale as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
CytoVale's investors include Blackhorn Ventures, National Science Foundation, Alumni Ventures, Norwest Venture Partners and Sands Capital Ventures, and 3 more on record.
CytoVale has raised $19M across 4 rounds since 2013. 2 rounds did not disclose an amount, so the total is a floor.
CytoVale's most recent round was a Venture in Apr 2025.
CytoVale's largest round on record is $15M (Undisclosed round), in Oct 2019.
CytoVale's first round on record, in Nov 2013, was backed by Breakout Labs.
CytoVale's latest named round is a Venture, in Apr 2025.
CytoVale is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
